Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Yelena Krijanovski, MD, Nicholas Donato, PhD, Alfonso Quintas-Cardama, MD, Jorge Cortes, MD, Moshe Talpaz, MD

Blood (2007) 110 (11): 1957.

https://doi.org/10.1182/blood.V110.11.1957.1957

Published: 2007

Journal Articles

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Zia Shariat-Madar, Fakhri Mahdi, Mark Warnock, Jonathon W. Homeister, Sujata Srikanth, Yelena Krijanovski, Laine J. Murphey, Ayad A. Jaffa, Alvin H. Schmaier

Blood (2006) 108 (1): 192–199.

https://doi.org/10.1182/blood-2006-01-0094

Published: 2006

Journal Articles

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Marvin T. Nieman, PhD, Eileen Pagan-Ramos, PhD, Mark Warnock, MA, Yelena Krijanovski, MD, Ahmed A.K. Hasan, MD, PhD, Alvin H. Schmaier, MD

Blood (2004) 104 (11): 1847.

https://doi.org/10.1182/blood.V104.11.1847.1847

Published: 2004

Journal Articles

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Ziaeddin Shariat-Madar, PhD, Mark Warnock, MA, Fakhri Mahdi, MA, Sujata Srikanth, MA, Yelena Krijanovski, MD, Alvin H. Schmaier, MD

Blood (2004) 104 (11): 801.

https://doi.org/10.1182/blood.V104.11.801.801

Published: 2004

Journal Articles

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Yelena Krijanovski, Valerie Proulle, Fakhri Mahdi, Marie Dreyfus, Werner Müller-Esterl, Alvin H. Schmaier

Blood (2003) 101 (11): 4430–4436.

https://doi.org/10.1182/blood-2002-11-3329

Published: 2003

NARROW

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Email alerts

ASH Publications

American Society of Hematology

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only